Purdue Pulls New OxyContin Application, and Questions Follow

MedPage TodayPurdue Pulls New OxyContin Application, and Questions FollowMedPage Todaysavesaved. author name. by Kristina Fiore Staff Writer, MedPage Today. Purdue's withdrawal of a supplemental New Drug Application related to its abuse-deterrent formulation of OxyContin has raised questions about postmarketing requirements for the drug.In rare move, Purdue pulls out of abuse-deterrent OxyContin meeting with FDABioPharma DiveOxyContin Maker Bows Out of Meeting on Harder-To-Abuse DrugNew York TimesPurdue pulls out of FDA panel on abuse-deterrent OxyContin just days before ...FierceBiotechall 77 news articles »